Xun Dong
Director/Board Member bij SINOMAB BIOSCIENCE LIMITED
Profiel
Xun Dong is currently the Director at Yunnan Institute of Materia Medica and a Non-Executive Director at Sinomab Bioscience Ltd.
He previously worked as the Vice President-Sales at Yunnan Baiyao Group Co., Ltd.
Mr. Dong received his graduate degree from the University of Warwick in 2010 and his undergraduate degree from Southampton Business School in 2009.
Actieve functies van Xun Dong
Bedrijven | Functie | Begin |
---|---|---|
SINOMAB BIOSCIENCE LIMITED | Director/Board Member | 23-12-2019 |
Yunnan Institute of Materia Medica
Yunnan Institute of Materia Medica Pharmaceuticals: MajorHealth Technology Part of Yunnan Baiyao Group Co., Ltd., Yunnan Institute of Materia Medica is a Chinese pharmaceutical company that manufactures and distributes drugs. The private company is based in Kunming, China. Yunnan Institute of Materia Medica was acquired by Yunnan Baiyao Group Co., Ltd. from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million. | Director/Board Member | - |
Eerdere bekende functies van Xun Dong
Bedrijven | Functie | Einde |
---|---|---|
YUNNAN BAIYAO GROUP CO.,LTD | Sales & Marketing | - |
Opleiding van Xun Dong
University of Warwick | Graduate Degree |
Southampton Business School | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
YUNNAN BAIYAO GROUP CO.,LTD | Health Technology |
SINOMAB BIOSCIENCE LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Yunnan Institute of Materia Medica
Yunnan Institute of Materia Medica Pharmaceuticals: MajorHealth Technology Part of Yunnan Baiyao Group Co., Ltd., Yunnan Institute of Materia Medica is a Chinese pharmaceutical company that manufactures and distributes drugs. The private company is based in Kunming, China. Yunnan Institute of Materia Medica was acquired by Yunnan Baiyao Group Co., Ltd. from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million. | Health Technology |